Phosphatidylethanolamine binding protein 1 in Alzheimer’s disease: ELISA development and clinical validation

Manuscript Number: 

22-0323R1

Author(s): 
Giovanni Bellomo, Davide Chiasserini, Lorenzo Gaetani, Silvia Paciotti, Federico Paolini Paoletti, Lucilla Parnetti, Anna Lidia Wojdała

Disclosures

Giovanni Bellomo

  • Patents/Royalties
    2019 – Co-inventor of a portable multifrequency bioimpedentiometer (Italian patent n° N. 102019000016184) for the analysis of body composition.

Davide Chiasserini

  • Nothing to Disclose

Lorenzo Gaetani

  • Lecture Fees:
    LGa participated on advisory boards for, and received writing honoraria and travel grants from Almirall, Biogen, Euroimmun, Fujirebio, Merck, Mylan, Novartis, Roche, Sanofi Genzyme, Siemens Healthineers and Teva.

Silvia Paciotti

  • Nothing to Disclose

Federico Paolini Paoletti

  • Nothing to Disclose

Lucilla Parnetti

  • Consulting Fees:
    Member and reviewer of the Swedish Research Council. Member and reviewer of the Research Council of Norway. Member and reviewer of the Icelandic Centre for Research.
    Patents/Royalties
    Co-owner of a European patent on CSF biomarkers in neurodegenerative diseases, developed as part of a collaboration between the University of Perugia and the University of the United Arab Emirates (European Patent Office Specification No. EP 2 591 367 B1). International publication number: WO 2012/004566 (12.01.2012 Gazette 2012/02).
    Grants
    • Agency: 
      Fujirebio

Anna Lidia Wojdała

  • Nothing to Disclose